首站-论文投稿智能助手
典型文献
Data Resource Profile: A Protocol of China National Diabetic Chronic Complications Study
文献摘要:
Diabetes affects approximately 10.5% of adults worldwide, and its chronic complications lead to severely disabling sequelae and premature death, thus placing a heavy healthcare burden on both patients affected and society[1]. China has experienced a dramatic increase in diabetes prevalence from 0.67% in 1980[2] to 12.8% in 2018[3] and has approximately one-quarter of people with diabetes worldwide[1]. It is therefore essential to understand the epidemiologic characteristics of the chronic complications and co-morbidities of diabetes, and the current status of diabetes management to guide planning for appropriate diabetes care and intervention for these complications and co-morbidities at the national level[4-7]. To date, however, no national population-based epidemiologic studies regarding diabetes-related complications and co-morbidities have been reported?in?China.
文献关键词:
作者姓名:
HOU Xu Hong;WANG Li Min;CHEN Si Yu;LIANG Ye Bei;ZHANG Mei;HUANG Zheng Jing;CHEN Hong Li;WU Jing Zhu;WU Jing;JIA Wei Ping
作者机构:
Department of Endocrinology and Metabolism,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease,Shanghai 200233,China;National Center for Chronic and Noncommunicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;Department of Endocrinology and Metabolism,Suzhou Dushu Lake Hospital(Dushu Lake Hospital Affiliated to Soochow University),Suzhou 215000,Jiangsu,China;Department of Endocrinology and Metabolism,Shanghai General Hospital,Shanghai 200080, China
引用格式:
[1]HOU Xu Hong;WANG Li Min;CHEN Si Yu;LIANG Ye Bei;ZHANG Mei;HUANG Zheng Jing;CHEN Hong Li;WU Jing Zhu;WU Jing;JIA Wei Ping-.Data Resource Profile: A Protocol of China National Diabetic Chronic Complications Study)[J].生物医学与环境科学(英文版),2022(07):633-640,中插1-中插12
A类:
B类:
Data,Resource,Profile,Protocol,China,National,Diabetic,Chronic,Complications,Study,Diabetes,affects,approximately,adults,worldwide,its,chronic,complications,lead,severely,disabling,sequelae,premature,death,thus,placing,heavy,healthcare,burden,both,patients,affected,society,has,experienced,dramatic,increase,diabetes,prevalence,from,one,quarter,people,It,therefore,essential,understand,epidemiologic,characteristics,morbidities,current,status,management,guide,planning,appropriate,intervention,these,national,level,To,date,however,no,population,studies,regarding,related,have,been,reported
AB值:
0.658834
相似文献
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Improving the surveillance and response system to achieve and maintain malaria elimination: a retrospective analysis in Jiangsu Province, China
Cao Yuanyuan;Lu Guangyu;Cotter Chris;Wang Weiming;Yang Mengmeng;Liu Yaobao;Liang Cheng;Zhou Huayun;Lu Yan;Yan Jun;Zhu Guoding;Cao Jun-Key Laboratory of National Health Commission (NHC) On Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory On Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, Jiangsu, China;Institute of Public Health, Medical College of Yangzhou University, Jiangsu Province, Yangzhou city 225000, China;Malaria Elimination Initiative, Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA;Department of Women’s and Children’s Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden;Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China;Health and Quarantine Department, Nanjing Customs, Nanjing 210001, China;Chinese Center for Disease Control and Prevention, Beijing 102206, China
Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
Wei Yumei;Juan Juan;Su Rina;Song Geng;Chen Xu;Shan Ruiqin;Li Ying;Cui Shihong;Fan Shangrong;Feng Ling;You Zishan;Meng Haixia;Cai Yan;Zhang Cuilin;Yang Huixia-Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China;Department of Obstetrics, Tianjin Central Obstetrics and Gynecology Hospital, Tianjin 300199, China;Department of Obstetrics, Jinan Maternal and Child Health Hospital, Jinan, Shandong 250000, China;Department of Obstetrics, Dalian Maternity Hospital, Dalian, Liaoning 116033, China;Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China;Department of Obstetrics, Shenzhen Peking University Hospital, Shenzhen, Guangdong 518036, China;Department of Obstetrics and Gynecology, Tongji Hospital Affiliated to Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Obstetrics and Gynecology, Suzhou Jiulong Hospital Affiliated to Shanghai Jiaotong University, Suzhou, Jiangsu 320571, China;Department of Obstetrics, Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010050, China;Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China;Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, USA
Quality metrics and outcomes among critically ill patients in China: results of the national clinical quality control indicators for critical care medicine survey 2015-2019
Rui Xi;Dong Fen;Ma Xudong;Su Longxiang;Shan Guangliang;Guo Yanhong;Long Yun;Liu Dawei;Zhou Xiang-Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100029, China;Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China;Department of Medical Administration, National Health Commission of the People’s Republic of China, Beijing 100044, China;Department of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Chinese Academy of Medical Sciences (CAMS) & School of Basic Medicine, Peking Union Medical College, Beijing 100005, China
Epidemiological characteristics of pulmonary tuberculosis in patients with pneumoconiosis based on its social determinants and risk factors in China: a cross-sectional study from 27 provinces
Wang Huanqiang;Dai Huaping;He Jiayu;Lyu Xiangpei;Zhang Xinran;Li Tao-Department of Occupational Respiratory Disease, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China;National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100029, China;Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China;Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China
Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology,Complications and Comorbidities
WANG Shan-shan;ZENG Xian;WANG Ya-li;Zhuoma Dongzhi;ZHAO Yu-fen;CHEN Yu-zong-Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences,Institute of Drug Discovery Technology,Ningbo University,Ningbo,Zhejiang Province,315211,China;Department of Biological Medicines&Shanghai Engineering Research Center of Immunotherapeutics,Fudan University School of Pharmacy,Shanghai,201203,China;Bioinformatics and Drug Design Group,Department of Pharmacy,National University of Singapore,,117543,Singapore;Medical College,Tibet University,Lhasa,850011,China;Department of Chemical Biology,College of Chemistry and Chemical Engineering,and The Key Laboratory for Chemical Biology of Fujian Province,Xiamen University,Xiamen,Fujian Province,361005,China;Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology,Ministry of Education,Department of Chemistry,Tsinghua University,Beijing,102206,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。